Working… Menu
Trial record 3 of 17 for:    neuroblastoma, IL2

CH14.18 1021 Antibody and IL2 After Haplo SCT in Children With Relapsed Neuroblastoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02258815
Recruitment Status : Unknown
Verified October 2014 by Peter Lang, University Children's Hospital Tuebingen.
Recruitment status was:  Recruiting
First Posted : October 7, 2014
Last Update Posted : October 7, 2014
Information provided by (Responsible Party):
Peter Lang, University Children's Hospital Tuebingen

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : December 2014
Estimated Study Completion Date : December 2015